Antidepressant drugs: Disturbing and potentially dangerous adverse effects

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 16, 1998, Pages 25-30

  Settle Jr , Edmund C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BETHANECHOL; CENTRAL STIMULANT AGENT; CLOMIPRAMINE; CYPROHEPTADINE; DEMECLOCYCLINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MAPROTILINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; PROCAINAMIDE; PROPRANOLOL; QUINIDINE GLUCONATE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; YOHIMBINE;

APATHY; BLOOD TOXICITY; CARDIOTOXICITY; COGNITIVE DEFECT; CONDUCTION DEAFNESS; DEPRESSION; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SLEEP DISORDER; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEPRESSIVE DISORDER; DRUG UTILIZATION; HUMANS; INAPPROPRIATE ADH SYNDROME; SEIZURES; SEROTONIN SYNDROME; SLEEP DISORDERS;

EID: 3543114251     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970;117:437-438
2. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
3. Isacsson G, Holmgren P, Wasserman D, et al. Use of antidepressants among people committing suicide in Sweden. BMJ 1994;308:506-509
4. Isacsson G, Bergman U, Rich CL. Antidepressants, depression and suicide: an analysis of the San Diego study. J Affect Disord 1994;32:277-286
5. Isacsson G, Holmgren P, Druid H, et al. The utilization of antidepressants - a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatr Scand 1997;96:94-100
6. Marzuk PM, Tardiff K, Leon AC, et al. Use of prescription psychotropic drugs among suicide victims in New York City. Am J Psychiatry 1995;152:1520-1522
7. Rich CL, Isacsson G. Suicide and antidepressants in south Alabama: evidence for improved treatment of depression. J Affect Disord 1997;45:135-142
8. Coppen A. Depression as a lethal disease: prevention strategies. J Clin Psychiatry 1994;55(4, suppl):37-45
9. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11
10. Glassman AH, Preud'homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 1993;54(2, suppl):16-22
11. Buff DD, Brenner R, Kirtane SS, et al. Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry 1991;52:174-176
12. Feder R. Bradycardia and syncope induced by fluoxetine [letter with reply]. J Clin Psychiatry 1991;52:139
13. Roose SP, Dalack GW, Woodring S. Death, depression, and heart disease. J Clin Psychiatry 1991;52(6, suppl):34-39
14. Effexor (venlafaxine). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1998:3037-3041
15. Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and indifference in patients on fluvoxamine and fluoxetine. J Clin Psychopharmacol 1990;10:343-345
16. Hoehn-Saric R, Harris GJ, Pearlson GD, et al. A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient. J Clin Psychiatry 1991;52:131-133
17. Baldessarini RJ, Marsh E. Fluoxetine and side effects. Arch Gen Psychiatry 1990;47:191-192
18. Gill HS, DeVane CL, Risch SC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997;17:377-389
19. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997;17:208-221
20. Mills KC. Serotonin syndrome. Am Fam Physician 1995;52:1475-1482
21. Spigset O, Hedenmalm K. Hyponatremia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995;12:209-225
22. Liu BA, Mittmann N, Knowles SR, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. Can Med Assoc J 1996;155:519-527
23. 2A receptor status. J Clin Psychopharmacol 1997;17:292-297
24. Spigset O, Hedenmalm K. Hyponatremia during treatment with clomipramine, perphenazine, or clozapine: study of therapeutic drug monitoring samples. J Clin Psychopharmacol 1996;16:412-414
25. Tielens JAE. Vitamin C for paroxetine- and fluvoxamine-associated bleeding. Am J Psychiatry 1997;153:883-884
26. Levin GM, DeVane CL. A review of cyclic antidepressant-induced blood dyscrasias. Ann Pharmacother 1992;26:378-383
27. Strom BL, Carson JL, Schinnar R, et al. Descriptive epidemiology of agranulocytosis. Arch Intern Med 1992;152:1475-1480
28. Trescoli-Serrano C, Smith NK. Sertraline-induced agranulocytosis [letter]. Postgrad Med J 1996;72:446
29. Sussman N, Stahl S. Update in the pharmacotherapy of depression. Am J Med 1996;101(6A, suppl):26S-36S
30. Peck AW, Stern WC, Watkinson C. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. J Clin Psychiatry 1983;44:197-201
31. Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992;53:160-162
32. Johnston JA, Lineberry CG, Ascher JA, et al. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 1991;52:450-456
33. Agargün MY, Kara H, Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 1997;58:249-251
34. Reynolds CF III, Frank E, Houck PR, et al. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? Am J Psychiatry 1997;154:958-962
35. Modell JG, Katholi CR, Modell JD, et al. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997;61:476-487
36. Kavoussi RJ, Segraves RT, Hughes AR, et al. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 1997;58:532-537
37. Feiger A, Kiev A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57(suppl 2):53-62
38. Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995;10(4, suppl):37-45
39. Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994;55:406-413